Efficacy and Safety of Drugs Available for the Treatment of Nocturnal Enuresis
- 3 Downloads
Nocturnal enuresis is a symptom which causes distress in children and concern in parents. In order to prevent secondary emotional problems, enuresis deserves intervention. Treatment options can address several mechanisms. Urine production can be decreased by use of desmopressin treatment or fluid restrictions. Functional bladder size can be increased using imipramine treatment or bladder stretching exercises. While desmopressin and imipramine may have similar efficacy, desmopressin is a superior drug in terms of safety. Dryness also can be achieved by learning to wake at night using self-awakening programmes or enuresis alarms. Enuresis alarms continue to have the highest efficacy and the lowest relapse rate. Combined programmes using alarms and medication together can bring successful outcomes to most children.
KeywordsImipramine Drug Invest Oxybutynin Desmopressin Bladder Capacity
Unable to display preview. Download preview PDF.
- Bakwin H. Enuresis in twins. American Journal of Diseases of Children 21: 222–225, 1971Google Scholar
- Blackwell B, Currah J. The psychopharmacology of nocturnal enuresis. In Kolvin I, et al. (Eds) Bladder control and enuresis, pp. 231–257, William Heinemann Medical Books, London, 1973Google Scholar
- De Jonge GA. Epidemiology of enuresis in bladder control and enuresis. In Kolvin et al. (Eds) pp. 39–46, Heinemann, London, 1973Google Scholar
- Evans JHC. The efficacy of DDAVP in the treatment of nocturnal enuresis. In Meadow R (Ed.) Desmopressin in nocturnal enuresis. Proceedings of an International Symposium, London, 1989Google Scholar
- Hague M, Ellerstein NS, Gundy JH, Shelov SP, Weiss JC, et al. Parental perceptions of enuresis: a collaborative study. American Journal of Diseases of Children 135: 809–811, 1981Google Scholar
- Holt J, Borresen B. Enuresis nocturnal in school children in Bado. A therapeutic trial with a vasopressin analog: desmopressin and imipramine. Tidskkrift for den Norske Laegeforening 106: 651–654, 1986Google Scholar
- Lovering JS, Tallett SE, McKendry JBJ. Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics 81: 104–106, 1988Google Scholar
- Meadow SR. Management of nocturnal enuresis. In Meadow R (Ed.) Desmopressin in nocturnal enuresis. Proceedings of an International Symposium, London, pp. 16–21, 1989Google Scholar
- Rittig S, Knudsen UB, Sorensen S, et al. Long-term double-blind cross-over study of desmopressin intranasal spray in the management of nocturnal enuresis. In Meadow R (Ed.) Desmopressin in nocturnal enuresis. Proceedings of an International Symposium, pp. 43-54, London, 1989bGoogle Scholar
- Schmitt BD. New enuresis alarms: safe, successful, and child-operable. Contemporary Pediatrics 3: 77–84, 1986Google Scholar
- Turner RK. Conditioning treatment of nocturnal enuresis: present status. In Kolvin L, et al. (Eds) Bladder control and enuresis, pp. 195–210, William Heinemann Medical Books, London, 1973Google Scholar